| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Eleonora Aronica | Q66943614 |
| Annamaria Vezzani | Q66943699 | ||
| P2093 | author name string | Silvia Balosso | |
| Teresa Ravizza | |||
| P2860 | cites work | Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain. | Q35103371 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neuroglia | Q177105 |
| P304 | page(s) | 24-32 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Epilepsia | Q5382969 |
| P1476 | title | Glia as a source of cytokines: implications for neuronal excitability and survival | |
| P478 | volume | 49 Suppl 2 |
| Q38246632 | A Molecular Approach to Epilepsy Management: from Current Therapeutic Methods to Preconditioning Efforts |
| Q51886367 | Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development. |
| Q34073789 | Adenosine dysfunction and adenosine kinase in epileptogenesis |
| Q36036212 | Adenosine dysfunction in epilepsy |
| Q36187095 | Altered synaptic transmission in the hippocampus of transgenic mice with enhanced central nervous systems expression of interleukin-6. |
| Q34540232 | Anti‐inflammatory effects of the anticonvulsant drug levetiracetam on electrophysiological properties of astroglia are mediated via TGFβ1 regulation |
| Q34617250 | Apoptosis, Bcl-2 family proteins and caspases: the ABCs of seizure-damage and epileptogenesis? |
| Q39096668 | Association of genetic polymorphism of pre-microRNA-146a rs2910164 and serum high-mobility group box 1 with febrile seizures in Egyptian children. |
| Q37983788 | Astrocyte immune responses in epilepsy |
| Q55286730 | Astroglial role in the pathophysiology of status epilepticus: an overview. |
| Q58610288 | Blocking TNFα-driven astrocyte purinergic signaling restores normal synaptic activity during epileptogenesis |
| Q38058370 | Blood-brain barrier dysfunction in brain diseases: clinical experience |
| Q30822690 | Brain region and epilepsy-associated differences in inflammatory mediator levels in medically refractory mesial temporal lobe epilepsy |
| Q36642774 | Cerebral Response to Peripheral Challenge with a Viral Mimetic |
| Q54440214 | Changes in microglial inflammation-related and brain-enriched MicroRNAs expressions in response to in vitro oxygen-glucose deprivation. |
| Q47653416 | Commonalities in epileptogenic processes from different acute brain insults: Do they translate? |
| Q35956389 | Comorbidities in Neurology: Is adenosine the common link? |
| Q92610150 | Cyclosporin A ameliorates eclampsia seizure through reducing systemic inflammation in an eclampsia-like rat model |
| Q41817638 | Cytokines and strokes of ill fortune |
| Q90756629 | Depressive, inflammatory, and metabolic factors associated with cognitive impairment in patients with epilepsy |
| Q49058385 | Dietary supplementation with α-tocopherol reduces neuroinflammation and neuronal degeneration in the rat brain after kainic acid-induced status epilepticus |
| Q53601228 | Early Life Stress Alters Adult Inflammatory Responses in a Mouse Model for Depression. |
| Q34260757 | Epilepsy and epileptic syndrome. |
| Q37394805 | Epilepsy, regulation of brain energy metabolism and neurotransmission |
| Q61807020 | Evidence for Innate and Adaptive Immune Responses in a Cohort of Intractable Pediatric Epilepsy Surgery Patients |
| Q90400677 | FK506 Attenuated Pilocarpine-Induced Epilepsy by Reducing Inflammation in Rats |
| Q28066813 | Fluid Biomarkers of Traumatic Brain Injury and Intended Context of Use |
| Q35232595 | Genome-wide circulating microRNA expression profiling indicates biomarkers for epilepsy |
| Q44075497 | Glial activation precedes seizures and hippocampal neurodegeneration in measles virus-infected mice |
| Q51831040 | Glial cells on the radar. |
| Q35072901 | Homeostatic bioenergetic network regulation - a novel concept to avoid pharmacoresistance in epilepsy |
| Q33934678 | IL-1β associations with posttraumatic epilepsy development: a genetics and biomarker cohort study. |
| Q60549396 | Increased expression of matrix metalloproteinase 3 can be attenuated by inhibition of microRNA-155 in cultured human astrocytes |
| Q47419527 | Increased neuronal seizure activity correlates with excessive systemic inflammation in a rat model of severe preeclampsia |
| Q42018190 | Inflammation enhances epileptogenesis in the developing rat brain |
| Q48169525 | Inflammation induced at different developmental stages affects differently the range of microglial reactivity and the course of seizures evoked in the adult rat. |
| Q38969134 | Inflammatory aspects of epileptogenesis: contribution of molecular inflammatory mechanisms |
| Q44476509 | Inflammatory changes during epileptogenesis and spontaneous seizures in a mouse model of mesiotemporal lobe epilepsy. |
| Q47128001 | Inhibition of cyclin-dependent kinase 5 affects early neuroinflammatory signalling in murine model of amyloid beta toxicity. |
| Q34613704 | Innate but not adaptive immune responses contribute to behavioral seizures following viral infection |
| Q48469394 | Interleukin-1β and microRNA-146a in an immature rat model and children with mesial temporal lobe epilepsy |
| Q35077723 | Interleukin-6, produced by resident cells of the central nervous system and infiltrating cells, contributes to the development of seizures following viral infection |
| Q90095461 | Is cannabidiol a drug acting on unconventional targets to control drug-resistant epilepsy? |
| Q48239099 | Lacosamide improves outcome in a murine model of traumatic brain injury |
| Q46394278 | MRI changes and complement activation correlate with epileptogenicity in a mouse model of temporal lobe epilepsy |
| Q46306150 | Magnesium Sulfate Provides Neuroprotection in Eclampsia-Like Seizure Model by Ameliorating Neuroinflammation and Brain Edema |
| Q85122274 | Matrix metalloproteinase-9 may be a potential therapeutic target in epilepsy |
| Q35141073 | Mesial temporal lobe epilepsy with psychiatric comorbidities: a place for differential neuroinflammatory interplay |
| Q34427432 | MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response |
| Q35708750 | Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission. |
| Q42068183 | Microvesicles released from microglia stimulate synaptic activity via enhanced sphingolipid metabolism. |
| Q37677797 | Microvesicles shed from microglia activated by the P2X7-p38 pathway are involved in neuropathic pain induced by spinal nerve ligation in rats. |
| Q98956929 | MnSOD Ala16Val polymorphism in cognitive dysfunction in patients with epilepsy: A relationship with oxidative and inflammatory markers |
| Q28391535 | Models to identify treatments for the acute and persistent effects of seizure-inducing chemical threat agents |
| Q38138991 | Modulation of adult-born neurons in the inflamed hippocampus. |
| Q37821806 | Mood disorders and obesity: understanding inflammation as a pathophysiological nexus |
| Q55228929 | NADPH oxidases as potential pharmacological targets against increased seizure susceptibility after systemic inflammation. |
| Q36327838 | NMDA receptor antagonism with novel indolyl, 2-(1,1-Dimethyl-1,3-dihydro-benzo[e]indol-2-ylidene)-malonaldehyde, reduces seizures duration in a rat model of epilepsy. |
| Q45917260 | NNZ-2566, a glypromate analog, attenuates brain ischemia-induced non-convulsive seizures in rats. |
| Q97073856 | Neurobiology of coronaviruses: Potential relevance for COVID-19 |
| Q96306586 | Neurodegenerative pathways as targets for acquired epilepsy therapy development |
| Q35676304 | Neurotropic viral infections leading to epilepsy: focus on Theiler's murine encephalomyelitis virus |
| Q42178322 | Non-linear classification of heart rate parameters as a biomarker for epileptogenesis |
| Q37540412 | Pathogenesis of epilepsy: challenges in animal models |
| Q37238455 | Platelet-activating factor receptor antagonism targets neuroinflammation in experimental epilepsy |
| Q51755394 | Post-seizure α-tocopherol treatment decreases neuroinflammation and neuronal degeneration induced by status epilepticus in rat hippocampus. |
| Q36542199 | Postnatal inflammation increases seizure susceptibility in adult rats. |
| Q57844416 | Recent advances in psychoneuroimmunology: Inflammation in psychiatric disorders |
| Q36513532 | Regulation of Kir4.1 expression in astrocytes and astrocytic tumors: a role for interleukin-1 β |
| Q37587496 | Regulation of Physical Microglia-Neuron Interactions by Fractalkine Signaling after Status Epilepticus |
| Q91670106 | Role of Astrocytes in Post-traumatic Epilepsy |
| Q46375569 | Status epilepticus induces a particular microglial activation state characterized by enhanced purinergic signaling |
| Q30361410 | The Role of Glia in the Peripheral and Central Auditory System Following Noise Overexposure: Contribution of TNF-α and IL-1β to the Pathogenesis of Hearing Loss |
| Q36505024 | The TARC/sICAM5 Ratio in Patient Plasma is a Candidate Biomarker for Drug Resistant Epilepsy |
| Q34442604 | The impact of microglial activation on blood-brain barrier in brain diseases. |
| Q51730982 | The role of the microRNA-146a/complement factor H/interleukin-1β-mediated inflammatory loop circuit in the perpetuate inflammation of chronic temporal lobe epilepsy. |
| Q36975521 | Tumor necrosis factor-α and interleukin-6 concentrations in cerebrospinal fluid of dogs after seizures |
| Q38162945 | Understanding the spectrum of temporal lobe epilepsy: contributions for the development of individualized therapies |
| Q28569395 | Upregulation of adenosine kinase in astrocytes in experimental and human temporal lobe epilepsy |
| Q40335715 | miR-146a negatively regulates the induction of proinflammatory cytokines in response to Japanese encephalitis virus infection in microglial cells |
| Q92591413 | microRNA-132 is overexpressed in glia in temporal lobe epilepsy and reduces the expression of pro-epileptogenic factors in human cultured astrocytes |
Search more.